• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类肠道微生物组的遗传决定因素及其与健康和疾病的关联:一项表型全基因组关联研究。

Human genetic determinants of the gut microbiome and their associations with health and disease: a phenome-wide association study.

机构信息

Department of Cardiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.

Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.

出版信息

Sci Rep. 2020 Sep 8;10(1):14771. doi: 10.1038/s41598-020-70724-5.

DOI:10.1038/s41598-020-70724-5
PMID:32901066
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7479141/
Abstract

Small-scale studies have suggested a link between the human gut microbiome and highly prevalent diseases. However, the extent to which the human gut microbiome can be considered a determinant of disease and healthy aging remains unknown. We aimed to determine the spectrum of diseases that are linked to the human gut microbiome through the utilization of its genetic determinants as a proxy for its composition. 180 single nucleotide polymorphisms (SNPs) known to influence the human gut microbiome were used to assess the association with health and disease outcomes in 422,417 UK Biobank participants. Potential causal estimates were obtained using a Mendelian randomization (MR) approach. From the total sample analysed (mean age was 57 ± 8 years), 194,567 (46%) subjects were male. Median exposure was 66-person years (interquartile range 59-72). Eleven SNPs were significantly associated with 28 outcomes (Bonferroni corrected P value < 4.63·10) including food intake, hypertension, atopy, COPD, BMI, and lipids. Multiple SNP MR pointed to a possible causal link between Ruminococcus flavefaciens and hypertension, and Clostridium and platelet count. Microbiota and their metabolites might be of importance in the interplay between overlapping pathophysiological processes, although challenges remain in establishing causal relationships.

摘要

一些小规模的研究表明,人类肠道微生物组与高发疾病之间存在关联。然而,人类肠道微生物组在多大程度上可以被认为是疾病和健康衰老的决定因素尚不清楚。我们旨在通过利用其遗传决定因素作为其组成的替代物,确定与人类肠道微生物组相关的疾病谱。使用 180 个已知影响人类肠道微生物组的单核苷酸多态性(SNP)来评估 422417 名英国生物库参与者的健康和疾病结果的关联。使用孟德尔随机化(MR)方法获得潜在的因果估计。在分析的总样本中(平均年龄为 57±8 岁),194567(46%)名受试者为男性。中位暴露为 66 人年(四分位间距为 59-72)。有 11 个 SNP 与 28 个结果显著相关(Bonferroni 校正 P 值<4.63·10),包括饮食摄入、高血压、过敏、COPD、BMI 和脂质。多重 SNP-MR 表明,瘤胃球菌(Ruminococcus flavefaciens)和高血压之间可能存在因果关系,拟杆菌属(Clostridium)和血小板计数之间也可能存在因果关系。尽管在确定因果关系方面仍然存在挑战,但微生物组及其代谢物可能在重叠的病理生理过程相互作用中具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a1/7479141/37af7b5547d6/41598_2020_70724_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a1/7479141/0e80376947f6/41598_2020_70724_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a1/7479141/79842b8a98e3/41598_2020_70724_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a1/7479141/37af7b5547d6/41598_2020_70724_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a1/7479141/0e80376947f6/41598_2020_70724_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a1/7479141/79842b8a98e3/41598_2020_70724_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a1/7479141/37af7b5547d6/41598_2020_70724_Fig3_HTML.jpg

相似文献

1
Human genetic determinants of the gut microbiome and their associations with health and disease: a phenome-wide association study.人类肠道微生物组的遗传决定因素及其与健康和疾病的关联:一项表型全基因组关联研究。
Sci Rep. 2020 Sep 8;10(1):14771. doi: 10.1038/s41598-020-70724-5.
2
A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.一种基于数据驱动的研究体重在多种疾病中作用的方法:英国生物库中基于表型全基因组注册的病例对照研究。
Lancet Digit Health. 2019 Jul;1(3):e116-e126. doi: 10.1016/S2589-7500(19)30028-7. Epub 2019 Jun 27.
3
The Effects of Specific Gut Microbiota and Metabolites on IgA Nephropathy-Based on Mendelian Randomization and Clinical Validation.特定肠道菌群及其代谢物对 IgA 肾病的影响——基于孟德尔随机化和临床验证。
Nutrients. 2023 May 22;15(10):2407. doi: 10.3390/nu15102407.
4
Identification of host gene-microbiome associations in colorectal cancer patients using mendelian randomization.利用孟德尔随机化鉴定结直肠癌患者的宿主基因-微生物组关联。
J Transl Med. 2023 Aug 10;21(1):535. doi: 10.1186/s12967-023-04335-9.
5
Causal relationships between the gut microbiome, blood lipids, and heart failure: a Mendelian randomization analysis.肠道微生物组、血脂与心力衰竭之间的因果关系:孟德尔随机分析。
Eur J Prev Cardiol. 2023 Sep 6;30(12):1274-1282. doi: 10.1093/eurjpc/zwad171.
6
Evidence for genetic causal relationships between gut microbiome, metabolites, and myasthenia gravis: a bidirectional Mendelian randomization study.肠微生物组、代谢物与重症肌无力之间遗传因果关系的证据:双向孟德尔随机化研究。
Front Immunol. 2023 Dec 21;14:1279845. doi: 10.3389/fimmu.2023.1279845. eCollection 2023.
7
Mendelian randomization study of causal link from gut microbiota to colorectal cancer.基于肠道微生物组到结直肠癌因果关联的孟德尔随机化研究。
BMC Cancer. 2022 Dec 30;22(1):1371. doi: 10.1186/s12885-022-10483-w.
8
Causal Effects of Specific Gut Microbiota on Chronic Kidney Diseases and Renal Function-A Two-Sample Mendelian Randomization Study.特定肠道微生物群对慢性肾脏病和肾功能的因果影响:两样本孟德尔随机化研究。
Nutrients. 2023 Jan 11;15(2):360. doi: 10.3390/nu15020360.
9
Genetically Predicted Causality of 28 Gut Microbiome Families and Type 2 Diabetes Mellitus Risk.遗传预测的 28 种肠道微生物群家族与 2 型糖尿病风险的因果关系。
Front Endocrinol (Lausanne). 2022 Feb 3;13:780133. doi: 10.3389/fendo.2022.780133. eCollection 2022.
10
Association of gut microbiome with risk of intracranial aneurysm: a mendelian randomization study.肠道微生物组与颅内动脉瘤风险的关联:一项孟德尔随机化研究。
BMC Neurol. 2023 Jul 15;23(1):269. doi: 10.1186/s12883-023-03288-2.

引用本文的文献

1
Reframing type 1 diabetes through the endocannabinoidome-microbiota axis: a systems biology perspective.从内源性大麻素组-微生物群轴重新审视1型糖尿病:系统生物学视角
Front Endocrinol (Lausanne). 2025 May 29;16:1576419. doi: 10.3389/fendo.2025.1576419. eCollection 2025.
2
Preliminary Insights Into the Relationship Between the Gut Microbiome and Host Genome in Posttraumatic Stress Disorder.创伤后应激障碍中肠道微生物群与宿主基因组关系的初步见解
Genes Brain Behav. 2025 Jun;24(3):e70025. doi: 10.1111/gbb.70025.
3
Gut microbiota and epigenetic choreography: Implications for human health: A review.

本文引用的文献

1
Improving causality in microbiome research: can human genetic epidemiology help?改善微生物组研究中的因果关系:人类遗传流行病学能提供帮助吗?
Wellcome Open Res. 2020 Apr 24;4:199. doi: 10.12688/wellcomeopenres.15628.3. eCollection 2019.
2
The gut microbiome and heart failure: A better gut for a better heart.肠道微生物组与心力衰竭:更好的肠道,更好的心脏。
Rev Endocr Metab Disord. 2019 Dec;20(4):407-414. doi: 10.1007/s11154-019-09519-7.
3
Intestinal microbiome composition and its relation to joint pain and inflammation.肠道微生物群落组成及其与关节疼痛和炎症的关系。
肠道微生物群与表观遗传协调:对人类健康的影响:综述。
Medicine (Baltimore). 2024 Jul 19;103(29):e39051. doi: 10.1097/MD.0000000000039051.
4
Networks of gut bacteria relate to cardiovascular disease in a multi-ethnic population: the HELIUS study.肠道细菌网络与多民族人群的心血管疾病有关:HELIUS 研究。
Cardiovasc Res. 2024 Mar 30;120(4):372-384. doi: 10.1093/cvr/cvae018.
5
Editorial: Animal social behaviour and gut microbiome.社论:动物社会行为与肠道微生物群
Front Microbiol. 2023 Aug 7;14:1210717. doi: 10.3389/fmicb.2023.1210717. eCollection 2023.
6
Gut Microbiota and Microbial Metabolism in Early Risk of Cardiometabolic Disease.肠道微生物群和微生物代谢与心血管代谢疾病的早期风险。
Circ Res. 2023 Jun 9;132(12):1674-1691. doi: 10.1161/CIRCRESAHA.123.322055. Epub 2023 Jun 8.
7
The gut microbiota and depressive symptoms across ethnic groups.肠道微生物群与不同民族群体的抑郁症状。
Nat Commun. 2022 Dec 6;13(1):7129. doi: 10.1038/s41467-022-34504-1.
8
Causal risk factors for asthma in Mendelian randomization studies: A systematic review and meta-analysis.孟德尔随机化研究中哮喘的因果风险因素:系统评价与荟萃分析
Clin Transl Allergy. 2022 Nov;12(11):e12207. doi: 10.1002/clt2.12207.
9
Association between Microbiome-Related Human Genetic Variants and Fasting Plasma Glucose in a High-Cardiovascular-Risk Mediterranean Population.微生物组相关的人类遗传变异与高心血管风险地中海人群空腹血糖的关联。
Medicina (Kaunas). 2022 Sep 7;58(9):1238. doi: 10.3390/medicina58091238.
10
Microbiome-associated human genetic variants impact phenome-wide disease risk.微生物组相关的人类遗传变异影响表型全基因组疾病风险。
Proc Natl Acad Sci U S A. 2022 Jun 28;119(26):e2200551119. doi: 10.1073/pnas.2200551119. Epub 2022 Jun 24.
Nat Commun. 2019 Oct 25;10(1):4881. doi: 10.1038/s41467-019-12873-4.
4
Pattern Recognition Receptor-Mediated Chronic Inflammation in the Development and Progression of Obesity-Related Metabolic Diseases.模式识别受体介导的慢性炎症在肥胖相关代谢性疾病的发生和发展中的作用。
Mediators Inflamm. 2019 Sep 8;2019:5271295. doi: 10.1155/2019/5271295. eCollection 2019.
5
Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates.基于异质因果估计惩罚的孟德尔随机化稳健方法。
PLoS One. 2019 Sep 23;14(9):e0222362. doi: 10.1371/journal.pone.0222362. eCollection 2019.
6
A comprehensive assessment of demographic, environmental, and host genetic associations with gut microbiome diversity in healthy individuals.综合评估人口统计学、环境和宿主遗传因素与健康个体肠道微生物多样性的关系。
Microbiome. 2019 Sep 13;7(1):130. doi: 10.1186/s40168-019-0747-x.
7
Gut Microbiota and Fecal Levels of Short-Chain Fatty Acids Differ Upon 24-Hour Blood Pressure Levels in Men.男性 24 小时血压水平影响肠道微生物群和粪便短链脂肪酸水平。
Hypertension. 2019 Oct;74(4):1005-1013. doi: 10.1161/HYPERTENSIONAHA.118.12588. Epub 2019 Jul 29.
8
Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.肠道微生物群的改变及其与慢性肾脏病中炎症因子的相关性。
Front Cell Infect Microbiol. 2019 Jun 12;9:206. doi: 10.3389/fcimb.2019.00206. eCollection 2019.
9
Targeting the Immune System in Atherosclerosis: JACC State-of-the-Art Review.靶向动脉粥样硬化中的免疫系统:美国心脏病学会最新综述。
J Am Coll Cardiol. 2019 Apr 9;73(13):1691-1706. doi: 10.1016/j.jacc.2018.12.083.
10
Gut Microbiota Composition and Blood Pressure.肠道微生物组成与血压。
Hypertension. 2019 May;73(5):998-1006. doi: 10.1161/HYPERTENSIONAHA.118.12109.